Tag Archives: Massachusetts Institute of Technology

Research Position in Biomedical Signal processing & physiological modelling in Singapore

Position Description: We are recruiting PhD students  for projects within the Singapore-MIT Alliance for Research & Technology (SMART), to be supervised by MIT and NTU faculty. In those projects we apply mathematical engineering to problems in bioengineering and biochemistry, for example:

o Bayesian modeling of parasitic life cycle
o large-scale graphical models for functional genomics
o stochastic modeling and control engineering in the context of tissue generation.

About Us:

SMART is MIT’s first, and to-date only, research centre outside the United States.  It is also MIT’s largest international research programme.   MIT faculty members have laboratories at SMART, mentor postdoctoral associates and graduate students, and collaborate with universities, research institutes and industries in Singapore and Asia.

Micro-worms used for Continuos monitoring in Healthcare:A Revolution

Researchers at MIT and Northeastern have come up with a new system for monitoring biomedical indicators — such as levels of sodium or glucose in the blood — that could someday lead to implantable devices that would allow, for example, people with diabetes to check their blood sugar just by glancing at an area of skin. A number of researchers have developed microparticle-based systems — hollow, microscopic particles filled with specific chemicals — for monitoring biomedical conditions or for the selective delivery of drugs to certain organs or areas of the body. But one drawback of these systems is that the particles are small enough to be swept away from the initial site over time. The new system involves a different kind of microparticle that can avoid this problem. While traditional particles are spherical, the new particles are shaped like long tubes. The tubes’ narrow width, which is comparable to that of the previously studied microparticles, keeps the tubes’ contents in close proximity to blood or body tissue, making it easy for the particles to sense and respond to chemical or other conditions in their surroundings. The tubes’ relatively greater length keeps the tubes very well anchored in place for long-term monitoring, perhaps for months on end. The particles eventually could be used to monitor the glucose levels of diabetics or the salt levels of those with a condition that can cause swings in blood salt concentrations.

Innovation in Healthcare 2011 syposium @ MIT

The inaugural Innovation in Healthcare Symposium: Systems Thinking from Discovery to Delivery will take place Feb. 1 at the Massachusetts Institute of Technology’s Department of Biological Engineering, Center for Biomedical Innovation, and Engineering Systems Division, according to MIT

The day-long event, sponsored by Merrimack Pharmaceuticals, will be a forum to stimulate new ways of thinking about and addressing today’s greatest healthcare challenges, said MIT officials. The event will happen at MIT’s Kresge Auditorium.

The Symposium will consist of four multi-disciplinary expert panels structured around three major topics:

  • improving healthcare delivery to patients,
  • reversing the declining productivity of biomedical research, and

The Global Biomedical Imaging Fellowship of a Lifetime

Make an impact on YOUR CAREER – and on THE WORLD

DEADLINES:

  • Application: January 25th
  • Reference Letter Submission: February 1st

Questions?

With a focus on accelerating innovation in biomedical imaging, promoting translational research, and encouraging entrepreneurship, the Madrid-MIT M+Visión Consortium is currently recruiting bright young talent from all over the world – engineers, physicians, scientists, and entrepreneurs interested in biomedical imaging who are in search of a career-enhancing experience and want to make their mark on the world.

BIOMEDICAL INTERNSHIP PROGRAMMES ABROAD

General BME Internship Sites

University Internships

BIOMEDICAL ENGINEERS ARE GIFTED ONES ALWAYS

There’s Smart, and then there’s Mega-Smart
Biomedical engineers are smart people; this is a universal truth. As a rule, dim-witted people do not develop bioartificial organs or design pacemakers. But then there are the pioneers who have taken the biomedical field by storm over the past century, earning more awards and patents and inventing more devices than any mere mortal should. You could refer to this rare breed as The Ridiculously Smart Bioengineering Club, a league of gifted souls with DNA like Einstein’s.
What Do They Have in Common?
Let’s start with biophysicist Otto Schmitt. Though his parents weren’t scientists, Otto was exposed at the age of 16 to the work of his older brother Frank. Frank became a professor of zoology in 1929, and Otto was allowed to “gadgeteer” in Frank’s laboratory and create instrumentation (www.thebakken.org). Otto would also do experiments at home, much to his mother’s chagrin. His mom fainted when she went into his bedroom one day and saw Otto with sparks flying out of his nose and fingers; he had crafted his own rudimentary Tesla Ball out of spare parts to make his hair stand straight up. Despite his crazy antics with electricity, Otto survived his youth and went on to invent devices like the cathode follower.
Leslie Geddes has taught one-fifth of all biomedical engineers currently in practice. He’s patented everything from a baby pacifier that delivers medication to biomaterials (www.mit.edu). As a kid, Leslie’s dad would bring home radio parts from work for his son to tinker with. Because some relatives were physicians, Leslie decided he would like to combine electronics with medicine.
Extraordinary curiosity is a common theme in the early years of the genius bioengineers. Robert Langer, currently Professor of Chemical Engineering at MIT in Cambridge, received a Gilbert chemistry and microscope set from his parents as a young boy. He was fascinated watching chemical color changes, and enjoyed watching shrimp grow with his little microscope (www.thebiotechclub.org). This young chemist would grow up to receive more than 600 patents and 160 major awards, and be the most cited engineer in history. His controlled drug delivery developments have alleviated human pain for countless patients. The stubborn Langer is oft-quoted as saying, “A lot of times somebody will tell you that your idea, or your invention, can’t be done. I think that’s very rarely true. If you believe in yourself and if you really work hard and stick to it, I believe there is very little that is impossible.”
This stubbornness gene can be found in Alfred E. Mann, entrepreneurial physicist and philanthropist billionaire. He’s said, “To say we can’t do something because other people have failed is not good enough for me” (www.inhealth.org).
It seems the formula for biomedical engineering mega-success is one part insatiable curiosity, one part influence by mentors, two parts giftedness, and three parts stubbornness.
Reblog this post [with Zemanta]